Published in Cardiovascular Business Week, November 11th, 2008
"In contrast, we present evidence that JNK2 can have a protective role against AILI When male C57BL/6J wild type (WT) and JNK2(-/-) mice were treated with 300 mg APAP/kg, 90% of JNK2(-/-) mice died of ALF compared to 20% of WT mice within 48 h. The high susceptibility of JNK2(-/-) mice to AILI appears to be due in part to deficiencies in hepatocyte...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.